Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Although cavities are an important finding in Mycobacterium avium complex pulmonary disease (MAC-PD), there is little information regarding the types of cavities that indicate disease progression. This study was performed to identify cavity characteristics that were associated with disease progression in patients with MAC-PD.

Methods: This retrospective cohort study included 97 patients presenting with MAC-PD with cavities between December 2006 and June 2016. We compared initial and final computed tomography (CT) findings, classified 52 and 45 patients in the progressive and non-progressive cavity groups, respectively, and examined the progression-related imaging features in initial CT images. A progressive cavity was defined by more than two-fold increase in internal diameter or emergence of a new cavity around the initial cavity.

Results: Patients in the progressive group were older (p < 0.001), had a lower body mass index (p = 0.043), and showed higher diabetes complication rates (p = 0.005). The initial CT in the progressive group showed a longer maximum internal diameter of the cavity (p < 0.001) and higher rates of cavities close to the chest wall (p < 0.001), multiple cavities (p = 0.023), consolidation around the cavity (p < 0.001), atelectasis (p = 0.011), and pleural thickening (p < 0.001). Multivariable logistic regression analysis revealed that the maximum internal diameter of the cavity (odds ratio [OR]: 1.11, 95% confidence interval [CI]: 1.02-1.21; p=0.012) and consolidation around the cavity (OR: 16.15, 95% CI: 4.05-64.46; p < 0.001) were significantly associated with progressive cavities. In cavities with a maximum internal diameter of ≥10 mm and simultaneous consolidation, the probability of progression was as high as 96.2%. The 10-year mortality rates in the progressive and non-progressive cavity groups were 46.7 and 9.8% (p < 0.001), respectively, while the 10-year respiratory failure rates were 28.1 and 0%, respectively (p < 0.001).

Conclusions: Large cavity size and consolidation on CT showed strong relationships with disease progression, which led to respiratory failure and high mortality rate.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950929PMC
http://dx.doi.org/10.1186/s12931-020-1273-xDOI Listing

Publication Analysis

Top Keywords

mycobacterium avium
8
avium complex
8
complex pulmonary
8
pulmonary disease
8
retrospective cohort
8
cohort study
8
disease progression
8
patients progressive
8
characteristic chest
4
chest findings
4

Similar Publications

A comparative study between milk- and serum-based antibody detection assays for Johne's disease in New Zealand dairy cattle.

Tuberculosis (Edinb)

August 2025

School of Agriculture & Environment, Massey University, Palmerston North 4442, New Zealand; Shreiber School of Veterinary Medicine, Rowan University, 1000 Gilbreth Parkway, Harrison Township, NJ, 08062, United States. Electronic address:

Dairy cattle are affected by Johne's disease. It is caused by Mycobacterium avium subspecies paratuberculosis (MAP). Suboptimal diagnostic tests add more to the productivity loss resulting from this disease.

View Article and Find Full Text PDF

Novel mutations associated with clofazimine resistance in Mycobacterium intracellulare.

J Antimicrob Chemother

September 2025

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Cen

Background: Clofazimine is a promising repurposed drug for treating Mycobacterium avium-intracellulare complex pulmonary disease, but its resistance mechanisms in Mycobacterium intracellulare remain poorly understood.

Objective: This study aims to elucidate the resistance mechanisms of M. intracellulare to clofazimine.

View Article and Find Full Text PDF

A 79-year-old female diagnosed with myelodysplastic syndrome (MDS) and germline GATA2 mutation, on compassionate cobimetinib, was admitted with subacute cough and dyspnea. Chest imaging demonstrated a new, large, left hilar mass and consolidation with scattered diffuse mediastinal, supraclavicular, and hilar lymphadenopathy. A core biopsy of the right supraclavicular lymph node was performed.

View Article and Find Full Text PDF

Exploring the role of circulating microRNAs as potential diagnostic markers in Mycobacterium paratuberculosis.

Vet Ital

September 2025

Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, India.

Extracellular vesicles (EVs) are cell-derived and play a notable role in the development of chronic diseases and can be used as biomarkers as they transport microRNAs (miRNA). Existing research has found that most miRNA functions are carried out via intercellular transmission of EVs, which can protect and sort miRNAs. Early detection of disease is crucial for controlling the spread of the disease and improving livestock prognosis.

View Article and Find Full Text PDF

Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases.

Allergy Asthma Clin Immunol

September 2025

Department of Physiological Science, University of California, 986 N Center Street, Orange, Los Angeles, CA, 90095, USA.

Background: Allergic bronchopulmonary aspergillosis (ABPA) presents with a wide range of symptom severity, with severe disease manifestations being harder to control through conventional inhalers. While corticosteroids remain a standard treatment option, their use is often hindered by significant adverse side effects. This case series discusses a novel treatment of duo-administration of monoclonal antibodies for two patients that reduced their exacerbations, spared the use of steroids, and improved their quality of life.

View Article and Find Full Text PDF